Time before return to play for the most common injuries in professional football: a 16-year follow-up of the UEFA Elite Club Injury Study.


Journal

British journal of sports medicine
ISSN: 1473-0480
Titre abrégé: Br J Sports Med
Pays: England
ID NLM: 0432520

Informations de publication

Date de publication:
Apr 2020
Historique:
accepted: 26 05 2019
pubmed: 12 6 2019
medline: 3 6 2020
entrez: 12 6 2019
Statut: ppublish

Résumé

The objective was to describe the typical duration of absence following the most common injury diagnoses in professional football. Injuries were registered by medical staff members of football clubs participating in the Union of European Football Association Elite Club Injury Study. Duration of absence due to an injury was defined by the number of days that passed between the date of the injury occurrence and the date when the medical team allowed the player to return to full participation. In total, 22 942 injuries registered during 494 team-seasons were included in the study. The 31 most common injury diagnoses constituted a total of 78 % of all reported injuries. Most of these injuries were either mild (leading to a median absence of 7 days or less, 6440 cases = 42%) or moderate (median absence: 7-28 days, 56% = 8518 cases) while only few (2% = 311 cases) were severe (median absence of >28 days). The mean duration of absence from training and competition was significantly different (p < 0.05) between index injuries and re-injuries for six diagnoses (Achilles tendon pain, calf muscle injury, groin adductor pain, hamstring muscle injuries and quadriceps muscle injury) with longer absence following re-injuries for all six diagnoses CONCLUSIONS: The majority of all time loss due to injuries in professional football stems from injuries with an individual absence of up to 4 weeks. This article can provide guidelines for expected time away from training and competition for the most common injury types as well as for its realistic range.

Identifiants

pubmed: 31182429
pii: bjsports-2019-100666
doi: 10.1136/bjsports-2019-100666
pmc: PMC7146935
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

421-426

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: TM work was partly sponsored by Saarland University and the German Football Association (DFB) via grants for the international PhD programme “Science and Health in Football”.

Références

Am J Sports Med. 2016 Aug;44(8):2112-21
pubmed: 27184543
Br J Sports Med. 2013 Aug;47(12):763-8
pubmed: 23770660
Br J Sports Med. 2016 Jun;50(12):709-10
pubmed: 27121295
Br J Sports Med. 2017 Jun;51(11):838-847
pubmed: 28446457
Br J Sports Med. 2016 Jun;50(12):731-7
pubmed: 26746908
Br J Sports Med. 2016 Jul;50(13):804-8
pubmed: 27162233
Br J Sports Med. 2012 Feb;46(2):112-7
pubmed: 22144005
Br J Sports Med. 2017 May;51(9):702-703
pubmed: 27633026
Am J Sports Med. 2011 Jun;39(6):1226-32
pubmed: 21335353
Pediatr Neurol. 2016 Sep;62:9-17
pubmed: 27421756
Am J Sports Med. 2013 Jan;41(1):111-5
pubmed: 23111807
Clin J Sport Med. 2005 Nov;15(6):436-41
pubmed: 16278548
Sports Health. 2011 Sep;3(5):423-30
pubmed: 23016038
J Sports Sci. 2014;32(13):1229-36
pubmed: 24784885
Br J Sports Med. 2016 Dec;50(24):1506-1515
pubmed: 27539507
Br J Sports Med. 2006 Mar;40(3):193-201
pubmed: 16505073
Br J Sports Med. 2017 Mar;51(5):419-420
pubmed: 27474390
Br J Sports Med. 2013 Aug;47(12):775-81
pubmed: 23760552
Br J Sports Med. 2002 Feb;36(1):6-10
pubmed: 11867482
Scand J Med Sci Sports. 2005 Feb;15(1):21-8
pubmed: 15679568
Br J Sports Med. 2013 Aug;47(12):732-7
pubmed: 23813543
Br J Sports Med. 2016 Jul;50(14):853-64
pubmed: 27226389
Br J Sports Med. 2005 Jun;39(6):340-6
pubmed: 15911603
Br J Sports Med. 2018 Aug;52(16):1018-1021
pubmed: 29021247
Am J Sports Med. 2007 Sep;35(9):1500-6
pubmed: 17426283
Unfallchirurg. 2018 Jun;121(6):433-440
pubmed: 29637217
Br J Sports Med. 2014 Oct;48(19):1447-50
pubmed: 25082616

Auteurs

Jan Ekstrand (J)

Department of Medical and Health Sciences, Linköping University, Linköping, Sweden jan.ekstrand@telia.com.
Aspetar Orthopaedic and Sports Medicine Hospital, Doha, Ad Dawhah, Qatar.

Werner Krutsch (W)

Department of Trauma Surgery, Universitatsklinikum Regensburg, Regensburg, Germany.

Armin Spreco (A)

Department of Medical and Health Sciences, Athletics Research Centre, Linköping University, Linköping, Sweden.

Wart van Zoest (W)

Department of Orthopaedic Surgery, St Anna Hospital, Eindhoven, The Netherlands.

Craig Roberts (C)

AFC Bournemouth, Bournemouth, Bournemouth, UK.

Tim Meyer (T)

Institute of Sports and Preventive Medicine, University of Saarland, Saarbrücken, Germany.

Håkan Bengtsson (H)

Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH